Ontvang nu dagelijks onze kooptips!

word abonnee
IEX 25 jaar
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
Markt vandaag Koersen Forum Premium IEX Expert
Home  /   Forum   /   Tigenix   /   Tigenix november 2017

Tigenix« Terug naar discussie overzicht

Tigenix november 2017

Volgen
436 Posts
Pagina: «« 1 ... 17 18 19 20 21 22 »» | Laatste | Omlaag ↓
  6. [verwijderd] 27 november 2017 00:23
    The Group directors concluded that the significant influence over its TiGenix investment has
    ceased. The facts that lead to that conclusion are the resignation of its preferred rights to
    distribute the main drug under investigation by TiGenix and the fact that Grifols Group has no
    longer appointed board members and do not expect to have any. Additionally it has been
    considered the fact that the time needed for exercising its right of appointment of one board
    director is too long as to allow Grifols to participate in the board decisions in due time.
    As a consequence the investment in TiGenix has been reclassified to Available for Sale Financial
    Assets. The effect of this reclassification resulted in a revaluation of the investment at fair value
    and the related gain amounting to Euros 24 million has been accounted for in Share of
  7. [verwijderd] 27 november 2017 00:43
    quote:

    four60 schreef op 26 november 2017 15:26:

    Ik heb een flinke pluk Tigenix en ga voor de langere termijn belegging tenzij ze worden overgenomen.
    Eens. Zo zie ik het ook.
    Er zijn gewoon zeer veel en zwaarwegende tekenen en feiten dat er een mooie toekomst is op de korte en op de wat langere termijn.

  8. Bio-marker 27 november 2017 08:39
    quote:

    TheBateman schreef op 27 november 2017 00:23:

    The Group directors concluded that the significant influence over its TiGenix investment has
    ceased. The facts that lead to that conclusion are the resignation of its preferred rights to
    distribute the main drug under investigation by TiGenix and the fact that Grifols Group has no
    longer appointed board members and do not expect to have any. Additionally it has been
    considered the fact that the time needed for exercising its right of appointment of one board
    director is too long as to allow Grifols to participate in the board decisions in due time.
    As a consequence the investment in TiGenix has been reclassified to Available for Sale Financial
    Assets. The effect of this reclassification resulted in a revaluation of the investment at fair value
    and the related gain amounting to Euros 24 million has been accounted for in Share of
    Dank hiervoor. Wat is bron en datum?
  9. Semper Nescio 27 november 2017 10:12
    quote:

    TheBateman schreef op 27 november 2017 00:23:

    The Group directors concluded that the significant influence over its TiGenix investment has
    ceased. The facts that lead to that conclusion are the resignation of its preferred rights to
    distribute the main drug under investigation by TiGenix and the fact that Grifols Group has no
    longer appointed board members and do not expect to have any. Additionally it has been
    considered the fact that the time needed for exercising its right of appointment of one board
    director is too long as to allow Grifols to participate in the board decisions in due time.
    As a consequence the investment in TiGenix has been reclassified to Available for Sale Financial
    Assets. The effect of this reclassification resulted in a revaluation of the investment at fair value
    and the related gain amounting to Euros 24 million has been accounted for in Share of
    Kun je even een link naar het volledige artikel bezorgen? Zou graag eens het volledige artikel lezen.
  12. Rider 27 november 2017 12:05
    quote:

    whoiam schreef op 27 november 2017 11:52:

    ik zit nog niet in tigenix, maar lees nu de laatste dagen dit forum, lijkt me een goed inkoopmoment met veel potentieel? ben aan het twijfelen voor deel kiadis te verkopen en deel tigenix te kopen, wat denken jullie?
    Ik zit in beide. Heb wel dubbel zoveel Kiadis als Tigenix.
  13. forum rang 5 posilies 27 november 2017 12:08
    quote:

    TheBateman schreef op 27 november 2017 00:23:

    The Group directors concluded that the significant influence over its TiGenix investment has
    ceased. The facts that lead to that conclusion are the resignation of its preferred rights to
    distribute the main drug under investigation by TiGenix and the fact that Grifols Group has no
    longer appointed board members and do not expect to have any. Additionally it has been
    considered the fact that the time needed for exercising its right of appointment of one board
    director is too long as to allow Grifols to participate in the board decisions in due time.
    As a consequence the investment in TiGenix has been reclassified to Available for Sale Financial
    Assets. The effect of this reclassification resulted in a revaluation of the investment at fair value
    and the related gain amounting to Euros 24 million has been accounted for in Share of
    Niet zo positief
436 Posts
Pagina: «« 1 ... 17 18 19 20 21 22 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Markt Vandaag

Stijgers

instrument koers absoluut verschil relatief verschil
AZERION 1,080 +0,06 +6,09%
Sif Holding 12,140 +0,38 +3,23%
BESI 133,500 +2,90 +2,22%
NX FILTRATION 3,290 +0,07 +2,17%
OCI 10,895 +0,21 +1,92%
TKH 33,180 +0,50 +1,53%
Avantium 1,760 +0,03 +1,50%
B&S Group SA 4,330 +0,05 +1,17%
THEON INTERNAT 12,500 +0,14 +1,13%
Air France-KLM 8,086 +0,09 +1,08%
Basic-Fit 21,660 +0,20 +0,93%
INPOST 16,300 +0,14 +0,87%
PostNL 1,030 +0,01 +0,78%
Accsys 0,556 +0,00 +0,72%
Galapagos 25,760 +0,18 +0,70%
Philips Koninklijke 24,330 +0,16 +0,66%
ForFarmers 3,420 +0,02 +0,59%
SIGNIFY NV 20,960 +0,12 +0,58%
UMG 24,510 +0,14 +0,57%
Corbion 21,480 +0,10 +0,47%
Nedap N.V. 54,000 +0,20 +0,37%
Vopak 42,160 +0,14 +0,33%
ASR Nederland 44,610 +0,13 +0,29%
Alfen N.V. 11,390 +0,03 +0,26%
SHELL PLC 29,270 +0,07 +0,26%
NN Group 41,470 +0,09 +0,22%
ING 14,748 +0,03 +0,22%
Fugro 16,280 +0,03 +0,18%
RANDSTAD NV 39,560 +0,07 +0,18%
Aegon 5,618 +0,00 +0,04%
Sligro 10,860 0,00 0,00%

Dalers

instrument koers absoluut verschil relatief verschil
Fagron 16,880 -1,24 -6,84%
EBUSCO HOLDING 1,094 -0,06 -4,85%
BAM 4,170 -0,13 -3,11%
Flow Traders 21,480 -0,60 -2,72%
ALLFUNDS GROUP 5,040 -0,13 -2,51%
JUST EAT TAKEAWAY 13,835 -0,30 -2,09%
HEIJMANS KON 30,800 -0,65 -2,07%
TomTom 4,904 -0,10 -2,02%
FASTNED 21,250 -0,35 -1,62%
ADYEN NV 1.420,000 -21,00 -1,46%
PROSUS 39,285 -0,58 -1,45%
ACOMO 17,100 -0,22 -1,27%
WDP 18,800 -0,24 -1,26%
Wolters Kluwer 159,500 -1,60 -0,99%
Kendrion 10,080 -0,10 -0,98%
IMCD 139,200 -1,35 -0,96%
ASCX 1.237,36 -11,51 -0,92%
Eurocommercial Properties 22,200 -0,20 -0,89%
Aperam 24,860 -0,22 -0,88%
RELX 43,440 -0,36 -0,82%
Pharming 0,874 -0,01 -0,80%
Wereldhave 13,720 -0,10 -0,72%
ArcelorMittal 22,130 -0,13 -0,58%
Brunel 8,710 -0,05 -0,57%
CM.COM 5,510 -0,03 -0,54%
SBM Offshore 16,710 -0,09 -0,54%
NSI 18,880 -0,10 -0,53%
AALBERTS NV 33,700 -0,16 -0,47%
UNILEVER PLC 54,780 -0,26 -0,47%
DSM FIRMENICH AG 97,420 -0,46 -0,47%
AMX 827,86 -3,84 -0,46%
Vastned 21,600 -0,10 -0,46%
KPN 3,493 -0,02 -0,46%
Ahold Delhaize 31,150 -0,14 -0,45%
JDE PEET'S 16,280 -0,07 -0,43%
Arcadis 58,450 -0,25 -0,43%
RENEWI 9,580 -0,04 -0,42%
ABN AMRO BANK N.V. 14,565 -0,05 -0,38%
AEX 872,22 -3,22 -0,37%
EXOR NV 88,050 -0,30 -0,34%
ASML 683,800 -2,30 -0,34%
AMG Critical Materials N.V. 13,610 -0,04 -0,29%
ASMI 562,800 -1,40 -0,25%
Akzo Nobel 55,740 -0,10 -0,18%
CTP 14,900 -0,02 -0,13%
Heineken 68,240 -0,08 -0,12%
Van Lanschot Kempen NV 42,750 -0,05 -0,12%
vlag naam koers verschil relatief verschil
AEX 872,22 -3,22 -0,37%
AEX GR 3.421,13 -12,65 -0,37%
Germany40^ 19.893,70 +44,93 +0,23%
FTSE 100 8.102,72 +18,11 +0,22%
EURO50 4.877,71 +17,93 +0,37%
US30^ 42.908,80 0,00 0,00%
Nasd100^ 21.487,90 0,00 0,00%
US500^ 5.972,84 0,00 0,00%
Japan225^ 39.312,70 0,00 0,00%
VD-NEW 15,69 -0,15 -0,98%
#/^ Index indications calculated real time, zie disclaimer